Congenital adrenal hyperplasia: genes and variants
Explore variant evidence for Congenital adrenal hyperplasia across 5 analyzed proteins (CYP21A2, CYP17A1, CYP11B1, HSD3B2, POR). Linked ClinVar records include 49 pathogenic or likely pathogenic variants, 1 variants of uncertain significance and 8 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Congenital adrenal hyperplasia
CYP21A2: Steroid 21-hydroxylase
It enables cortisol and aldosterone synthesis by 21-hydroxylating adrenal steroid precursors. Biallelic loss-of-function variants cause congenital adrenal hyperplasia, with cortisol deficiency, androgen excess, and in severe forms life-threatening salt wasting.
16 ClinVar pathogenic / likely pathogenic and 3 uncertain variants in CYP21A2 have source records linked to Congenital adrenal hyperplasia. Association strength is not clinical gene validity.
CYP17A1: Steroid 17-alpha-hydroxylase/17,20 lyase
Its 17-alpha-hydroxylase and 17,20-lyase activities direct adrenal and gonadal steroid synthesis toward glucocorticoids and sex steroids. Biallelic deficiency causes 17-alpha-hydroxylase/17,20-lyase deficiency with hypertension, hypokalemia, and impaired sexual development.
13 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in CYP17A1 have source records linked to Congenital adrenal hyperplasia. Association strength is not clinical gene validity.
CYP11B1: Cytochrome P450 11B1, mitochondrial
It catalyzes the final step of cortisol synthesis and also contributes to adrenal steroid metabolism. Biallelic loss-of-function variants cause 11-beta-hydroxylase-deficient congenital adrenal hyperplasia, characterized by cortisol deficiency, androgen excess, and frequently hypertension.
10 ClinVar pathogenic / likely pathogenic and 4 uncertain variants in CYP11B1 have source records linked to Congenital adrenal hyperplasia. Association strength is not clinical gene validity.
HSD3B2: 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2
It catalyzes an early essential step in adrenal and gonadal steroid synthesis, converting pregnenolone and related 3-beta-hydroxysteroids into progesterone-class intermediates. Biallelic deficiency causes congenital adrenal hyperplasia with impaired cortisol and aldosterone synthesis and variable disordered sex development.
8 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in HSD3B2 have source records linked to Congenital adrenal hyperplasia. Association strength is not clinical gene validity.
POR: NADPH--cytochrome P450 reductase
It transfers electrons from NADPH to microsomal cytochrome P450 enzymes, making it essential for steroid synthesis and metabolism of many drugs and xenobiotics. Biallelic pathogenic variants cause P450 oxidoreductase deficiency, with disordered steroidogenesis and skeletal abnormalities.
2 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in POR have source records linked to Congenital adrenal hyperplasia. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Congenital adrenal hyperplasia
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| CYP17A1 R440H | 440 | Pathogenic / likely pathogenic (★★) | |
| CYP17A1 R440C | 440 | Pathogenic / likely pathogenic (★★) | |
| CYP17A1 H373D | 373 | Pathogenic / likely pathogenic (★★) | |
| CYP17A1 H373Y | 373 | Pathogenic / likely pathogenic (★★) | |
| HSD3B2 P222Q | 222 | Pathogenic / likely pathogenic (★★) | |
| HSD3B2 P222T | 222 | Pathogenic / likely pathogenic (★★) | |
| CYP17A1 R96Q | 96 | Pathogenic / likely pathogenic (★★) | |
| CYP17A1 R96W | 96 | Pathogenic / likely pathogenic (★★) | |
| CYP17A1 R362C | 362 | Pathogenic / likely pathogenic (★★) | |
| HSD3B2 G12E | 12 | Pathogenic / likely pathogenic (★★) | |
| CYP11B1 R374Q | 374 | Pathogenic / likely pathogenic (★★) | |
| CYP17A1 P409L | 409 | Pathogenic / likely pathogenic (★★) | |
| CYP21A2 R92G | 92 | Pathogenic / likely pathogenic (★★) | |
| HSD3B2 N100S | 100 | Pathogenic / likely pathogenic (★★) | |
| POR G536R | 536 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| CYP11B1 W116C | 116 | Pathogenic / likely pathogenic (★★) | |
| CYP11B1 E371K | 371 | Pathogenic / likely pathogenic (★★) | |
| CYP17A1 R347C | 347 | Pathogenic / likely pathogenic (★★) | |
| CYP21A2 I237N | 237 | Pathogenic / likely pathogenic (★★) | |
| CYP21A2 V238E | 238 | Pathogenic / likely pathogenic (★★) | |
| HSD3B2 L173R | 173 | Pathogenic / likely pathogenic (★★) | |
| HSD3B2 T259M | 259 | Pathogenic / likely pathogenic (★★) | |
| CYP11B1 F79I | 79 | Pathogenic / likely pathogenic (★★) | |
| CYP11B1 A306V | 306 | Pathogenic / likely pathogenic (★★) | |
| CYP17A1 I332T | 332 | Pathogenic / likely pathogenic (★★) | |
| CYP21A2 M240K | 240 | Pathogenic / likely pathogenic (★★) | |
| CYP21A2 H366Y | 366 | Pathogenic / likely pathogenic (★★) | |
| POR L562P | 562 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| CYP11B1 L382R | 382 | Pathogenic / likely pathogenic (★★) | |
| CYP11B1 R454H | 454 | Pathogenic / likely pathogenic (★★) | |
| CYP17A1 M1I | 1 | Pathogenic / likely pathogenic (★★) | |
| CYP17A1 R358Q | 358 | Pathogenic / likely pathogenic (★★) | |
| CYP21A2 V282L | 282 | Pathogenic / likely pathogenic (★★) | |
| CYP21A2 R370W | 370 | Pathogenic / likely pathogenic (★★) | |
| CYP21A2 P483S | 483 | Pathogenic / likely pathogenic (★★) | |
| CYP21A2 R484Q | 484 | Pathogenic / likely pathogenic (★★) | |
| CYP17A1 A355T | 355 | Pathogenic / likely pathogenic (★) | |
| CYP21A2 R150P | 150 | Pathogenic / likely pathogenic (★) | |
| CYP11B1 T318P | 318 | Pathogenic / likely pathogenic (★) | |
| CYP21A2 R355H | 355 | Pathogenic / likely pathogenic (★) | |
| HSD3B2 P186L | 186 | Pathogenic / likely pathogenic (★) | |
| CYP21A2 I78T | 78 | Pathogenic / likely pathogenic (★) | |
| CYP21A2 C170R | 170 | Pathogenic / likely pathogenic (★) | |
| CYP21A2 L309F | 309 | Pathogenic / likely pathogenic (★) | |
| HSD3B2 A245P | 245 | Pathogenic / likely pathogenic (★) | |
| CYP11B1 M88I | 88 | Pathogenic / likely pathogenic (★) | |
| CYP21A2 P433L | 433 | Pathogenic / likely pathogenic (★) | |
| CYP11B1 R141Q | 141 | Pathogenic / likely pathogenic | |
| CYP21A2 I173N | 173 | Pathogenic / likely pathogenic |
Which prediction tools work for Congenital adrenal hyperplasia
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- VARITY: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 98 out of 100
- CADD: 98 out of 100
- MutPred: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 93 out of 100
- MetaSVM: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 93 out of 100
- phastCons: 93 out of 100
- MetaLR: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 91 out of 100
- SpliceAI: 67 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 53 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia also has ClinVar records linked to CYP21A2 variants; they fall partly in the same places as the Congenital adrenal hyperplasia variants (37 pathogenic / likely pathogenic).
- Deficiency of steroid 17-alpha-monooxygenase also has ClinVar records linked to CYP17A1 variants; they fall mostly in different places as the Congenital adrenal hyperplasia variants (40 pathogenic / likely pathogenic).
- 17-alpha-hydroxylase/17,20-lyase deficiency, combined complete also has ClinVar records linked to CYP17A1 variants; they fall partly in the same places as the Congenital adrenal hyperplasia variants (3 pathogenic / likely pathogenic).
- Deficiency of steroid 11-beta-monooxygenase also has ClinVar records linked to CYP11B1 variants; they fall partly in the same places as the Congenital adrenal hyperplasia variants (33 pathogenic / likely pathogenic).
- Glucocorticoid-remediable aldosteronism also has ClinVar records linked to CYP11B1 variants; they fall partly in the same places as the Congenital adrenal hyperplasia variants (20 pathogenic / likely pathogenic).
- 3 beta-Hydroxysteroid dehydrogenase deficiency also has ClinVar records linked to HSD3B2 variants; they fall mostly in different places as the Congenital adrenal hyperplasia variants (17 pathogenic / likely pathogenic).
- Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis also has ClinVar records linked to POR variants; they fall mostly in different places as the Congenital adrenal hyperplasia variants (7 pathogenic / likely pathogenic).
- Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency also has ClinVar records linked to POR variants; they fall mostly in different places as the Congenital adrenal hyperplasia variants (7 pathogenic / likely pathogenic).
Diseases related to Congenital adrenal hyperplasia
- Differences in sex development, also linked to CYP11B1, CYP17A1 and POR
- Deficiency of steroid 17-alpha-monooxygenase, also linked to CYP17A1
- 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia, also linked to CYP21A2
- Deficiency of steroid 11-beta-monooxygenase, also linked to CYP11B1
- Glucocorticoid-remediable aldosteronism, also linked to CYP11B1
- 3 beta-Hydroxysteroid dehydrogenase deficiency, also linked to HSD3B2
- Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis, also linked to POR
- Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, also linked to POR
- Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis, also linked to POR
- Prostate cancer, also linked to CYP17A1
- 17-alpha-hydroxylase/17,20-lyase deficiency, combined complete, also linked to CYP17A1
- Hypospadias, also linked to HSD3B2
Frequently asked questions
Which genes have records linked to Congenital adrenal hyperplasia?
This view contains 5 analyzed proteins: CYP21A2, CYP17A1, CYP11B1, HSD3B2, POR. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 49 pathogenic or likely pathogenic variants, 1 variants of uncertain significance and 8 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 81 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center